On September 1st,2023, a major milestone in military modernization was achieved when the U.S. Army awarded BAE Systems a full-rate production contract for the Armored Multi-Purpose Vehicle (AMPV), signaling a transformative era for Armored Brigade Combat Teams (ABCTs). With a contract valued at up to $797 million, nearly 3,000 AMPVs are set to replace the venerable but outdated M113 family of vehicles, constituting roughly 30 percent of the ABCT’s tracked vehicle fleet.
Maj. Gen. Glenn Dean, Program Executive Officer for Ground Combat Systems, emphasized the significance of the AMPV, stating, “The platform offers Soldiers better protection and survivability,” and “is a significant investment decision for the Army.” The design of the AMPV promises advancements in survivability and force protection, mobility, power, and the capability to integrate future technologies and the Army’s Network. These vehicles, which share a common powertrain and suspension with the M2 Bradley and M109A7 Paladin, will alleviate logistical and mechanical burdens, enhancing the operational capabilities of ABCTs.
BAE Systems in York, Pennsylvania, has commenced production of the AMPV, which is central to the Army’s “24 in 23” Modernization Signature Systems. This multi-phased program will witness the delivery of approximately 450 vehicles by the end of 2024, with full-rate production vehicles set to roll out beginning in 2025. The 1st Armored Brigade Combat Team completed its transition to AMPVs in July of the previous year, receiving over 130 vehicles and completing comprehensive training.
The new AMPV will be fielded in five distinct variants to meet diverse battlefield requirements:
- M1283 General Purpose (GP) Vehicle: This troop transport variant supports combat engineers, air-defense artillery troops, forward observers, and battalion and brigade headquarters personnel, typically armed with a .50-caliber machine gun.
- M1284 Medical Evacuation Vehicle: Functioning as an ambulance, this variant is equipped to transport casualties – “four litter casualties, six ambulatory (sitting) casualties, or a combination of two litter and three ambulatory casualties.”
- M1285 Medical Treatment Vehicle: A mobile surgery suite, the MT is designed to conduct field surgeries, hosting medical equipment and a treatment table.
- M1286 Mission Command Vehicle: Serving as a mobile tactical operations center with increased network capacity, this variant supports full command post capabilities at brigade and battalion levels.
- M1287 Mortar Carrier: Providing immediate mortar fire support, this variant is equipped with a 120-mm mortar and ammunition for responsive operations.
“The Army is transforming our ABCT through the integration of improved technology with warfighting concepts across the force. These modernization efforts increase our capacity to deter adversaries and if necessary, fight and win in combat,” said Col Peter Moon, commander, the 1st Armored Brigade Combat Team, 3rd Infantry Division. “We look forward to the capabilities that AMPV will bring to the battlefield to ensure we remain lethal and ready to win the fight.”
Relevant articles:
– Army awards full rate production contract for AMPV, Army.mil
– Purpose Vehicle: The U.S. Army’s Unsung Hero, popularmechanics.com
– Army delivers newest combat vehicle, Army.mil, Mar 14, 2023